Leading this expansion will be Duduzile Mathole, a direct selling industry veteran with experience in the local and regional regulations of South Africa regarding cannabis, who has been hired as Country Manager, South Africa.
Medical Marijuana, Inc., the parent company of direct selling organization Kannaway, announced a gross profit of $6.7 million and net revenue of $9.2 million for the third quarter of 2021.
Although the company has had an active presence in Finland for years, Finnish Customs confiscated a bottle of Kannaway Pure Gold in 2018, claiming it was illegally imported.
Kannaway, a direct selling subsidiary of Medical Marijuana, Inc., was recently honored at the 2021 CEO Awards with a Gold Globee for Executive Achievement of the Year in the Consumer Products category, an award given to organizations who set industry benchmarks for excellence.
The manufacturing subsidiary for Medical Marijuana, Inc. also experienced its largest revenue month in the division’s history.
Kannaway, a subsidiary of Medical Marijuana, Inc., has partnered with nonprofit The Por Grace Foundation to provide cannabidiol (CBD) products to families in need.
Medical Marijuana, Inc., announced that its subsidiary Kannaway has expanded its operations into Hong Kong. Kannaway plans to host regional education events for current and prospective distributors about the potential benefits of hemp-derived CBD oil.
The company’s net income and net revenue increased 8% and 86% respectively year-over-year. Net revenue totaled $9.6 million for the quarter while net income reached $7 million. Gross profit for the quarter was $5.6 million.
Medical Marijuana announced that its subsidiaries HempMeds Mexico, Kannaway Japan, as well as its third-party manufacturing and distribution business, each achieved their largest revenue months in their respective histories in July 2021.
Medical Marijuana, Inc., the publicly traded parent company of direct selling company Kannaway, announced its first quarter financial results for 2021. The company reported $8.9 million in net revenue and $3.7 million in net income for the quarter, as well as a cash position of $4.9 million. “Our operations made tremendous advancements in the first […]
Medical Marijuana, Inc. announced that the Japanese division of its subsidiary Kannaway had record sales in February 2021, the best sales month in company history. “When we first entered the Japanese market in late 2019, we were one of the first companies offering cannabidiol (CBD) products in the country and saw a great opportunity to […]
Kannaway, a subsidiary of Medical Marijuana, Inc., received Certified Drug Free approval from the Banned Substances Control Group (BSCG) for its broad-spectrum CBD product Pure Gold. This third-party certification provides a stamp of approval for Pure Gold, proving that the product meets quality specifications and is not contaminated with drugs or agents that could lead to […]